Back to Search

ROBERT SOIFFER, MD

MD

Medical Oncology Physician

NPI: 1780653261IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

56125(MA)

Education

NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Class of 1983

Research & Publications (20)

Immune modulation and chronic graft-versus-host disease.
PMID 18724307·Bone Marrow Transplant·2008
6-review
Donor lymphocyte infusions for acute myeloid leukaemia.
PMID 18790449·Best Pract Res Clin Haematol·2008
6-review
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
PMID 12947071·J Clin Oncol·2003
3-trial
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
PMID 12359762·Cancer Res·2002
8-other
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
PMID 11181681·J Clin Oncol·2001
3-trial
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
PMID 19539208·Biol Blood Marrow Transplant·2009
6-review
Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.
PMID 19203731·Biol Blood Marrow Transplant·2009
8-other
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
PMID 19159415·Transfusion·2009
3-trial
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
PMID 19509382·JAMA·2009
1-meta
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
PMID 19660719·Biol Blood Marrow Transplant·2009
8-other
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
PMID 19539216·Biol Blood Marrow Transplant·2009
3-trial
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation.
PMID 18974373·Blood·2009
3-trial
Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
PMID 19008459·Blood·2009
3-trial
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
PMID 19168788·Blood·2009
8-other
Variation in supportive care practices in hematopoietic cell transplantation.
PMID 18940677·Biol Blood Marrow Transplant·2008
8-other
Recurrent acute promyelocytic leukemia presenting as a sacral nerve root mass.
PMID 18591563·J Clin Oncol·2008
5-case
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.
PMID 18037942·Bone Marrow Transplant·2008
3-trial
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
PMID 18756547·Am J Hematol·2008
3-trial
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
PMID 18776081·Blood·2008
8-other
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
PMID 18640576·Biol Blood Marrow Transplant·2008
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
44 BINNEY ST, DANA FARBER CANCER INSTITUTE
BOSTON, MA 02115

Location

Practice Location

44 BINNEY ST, BOSTON, MA
(617) 632-4731

Quick Facts

NPI
1780653261
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
43
Publications
20

Are you this provider?

Claim Your Profile